There are at least 10,000 known monogenic diseases. When attempting to cure them, how do clinicians decide which gene-therapy delivery method is best?| www.asimov.press
Two new therapies—one which uses the gene-editing technology—treat sickle cell anemia.| TIME
Toxic amino acids, peptides, and proteins — which first evolved as molecular weapons deployed by species in conflict — can also serve as blueprints for pharmaceutical innovation.| www.asimov.press
Every year, roughly 2,000 babies are born with sickle cell disease, the most common inherited blood disorder in the United States. Children with sickle cell disease experience episodes of severe pain and ongoing medical challenges. Early and ongoing medical care can minimize complications and help children with the disorder lead full and active lives. Learn more here.| HealthyChildren.org
Learn how IoT and smart lab equipment can elevate your research capabilities and pave the way for long-term growth.| Forma Life Science Marketing
Personal site for posts about my interests: the biotech industry, medicine, molecular biology, neuroscience, biorisk, science, consciousness, AI, innovation, decision making, philosophy, games, sci-fi, probability, and forecasting (among other things). I write to learn, mostly about biotech.| Alex’s blog
20 of India's most thoughtful investors peer into 2024, spotlighting the trends and ideas that will shape India over the coming year| tigerfeathers.substack.com